Michael Mendicino

Michael Mendicino, Ph.D., is the President, Owner, Chief Consultant, and Advisor at Hybrid Concepts International, LLC, a consulting firm focused on cell therapy, gene therapies, regenerative medicine, and more since 2016. Currently serving as a Portfolio Advisor for Altius Bioventures and a member of the Scientific Advisory Board at RoslinCT, Michael Mendicino also holds leadership roles with the Alliance for Regenerative Medicine as the Chair of the Regulatory CMC Task Force and as a Co-Founder and Board Member of the Standards Coordinating Body. Previous positions include Head of Regulatory at Mana Therapeutics, Executive Vice President at RoosterBio Inc., and Director of Regulatory Affairs at Mesoblast. A former FDA Commissioner's Fellow, Michael Mendicino possesses an extensive educational background in immunology, business administration, and regulatory sciences.